GeneDx Holdings Corp. Class A Common Stock
$97.42
$2.78 (+2.94%)
$94.23Day Range$99.86
Key Statistics
Market Cap
$2.82B
Shares Outstanding
29.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 23, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$94.23
Day High
$99.86
Day Low
$94.23
Volume
792.0K
VWAP
$98.02
Prev Close
$94.64
Transactions
--
Acc. Volume
--
About GeneDx Holdings Corp. Class A Common Stock
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
SERVICES-HEALTH SERVICESSIC 80001,300 employees333 LUDLOW STREET, STAMFORD, CT, 06902888-729-1206IPO Jul 23, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001818331
- Composite FIGI
- BBG00XDHY5P9
- Share Class FIGI
- BBG00XDHY5R7
- Ticker Root
- WGS
- SIC Code
- 8000
About GeneDx Holdings Corp. Class A Common Stock (WGS) Stock
GeneDx Holdings Corp. Class A Common Stock (WGS) closed the 2026-09-16 session at $97.42, up 2.94% versus the previous close (+2.78). The stock opened at $94.23 and traded between $94.23 and $99.86 during that session. Session trading volume was 792K shares. The volume-weighted average price (VWAP) is $98.02.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
GeneDx Holdings Corp. Class A Common Stock has a market capitalization of $2.82 billion. The company operates in the SERVICES-HEALTH SERVICES industry classification. WGS is listed on the XNAS exchange. The company employs approximately 1,300 people. GeneDx Holdings Corp. Class A Common Stock is headquartered in STAMFORD, CT. The recorded listing date is 2021-07-23.
On this page you can find market WGS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-HEALTH SERVICES sector.